Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

NCT02201953

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Sacramento, California, United States
  • San Diego, California, United States
View all 76 locations
View Trial Details
Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

NCT02073656

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Newport Beach, California, United States
  • Palo Alto, California, United States
View all 41 locations
View Trial Details
Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

NCT02413593

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Calgary, Alberta, Canada
  • Edmonton, Alberta, Canada
  • Edmonton, Alberta, Canada
  • Vancouver, British Columbia, Canada
View all 15 locations
View Trial Details

Related conditions